Cingulate Inc. Warrants

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CINGW and buy or sell other stocks, ETFs, and their options commission-free!

About CINGW

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). 

CEO
Shane J. Schaffer, PharmD
CEOShane J. Schaffer, PharmD
Employees
—
Employees—
Headquarters
Kansas City, Kansas
HeadquartersKansas City, Kansas
Founded
2013
Founded2013
Employees
—
Employees—

CINGW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
9.85K
Average volume9.85K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.12
52 Week high$0.12
52 Week low
$0.0026
52 Week low$0.0026

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.